Correlation Between Actinogen Medical and Bluescope Steel

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Actinogen Medical and Bluescope Steel at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Actinogen Medical and Bluescope Steel into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Actinogen Medical and Bluescope Steel, you can compare the effects of market volatilities on Actinogen Medical and Bluescope Steel and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Actinogen Medical with a short position of Bluescope Steel. Check out your portfolio center. Please also check ongoing floating volatility patterns of Actinogen Medical and Bluescope Steel.

Diversification Opportunities for Actinogen Medical and Bluescope Steel

-0.69
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Actinogen and Bluescope is -0.69. Overlapping area represents the amount of risk that can be diversified away by holding Actinogen Medical and Bluescope Steel in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bluescope Steel and Actinogen Medical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Actinogen Medical are associated (or correlated) with Bluescope Steel. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bluescope Steel has no effect on the direction of Actinogen Medical i.e., Actinogen Medical and Bluescope Steel go up and down completely randomly.

Pair Corralation between Actinogen Medical and Bluescope Steel

Assuming the 90 days trading horizon Actinogen Medical is expected to generate 1.75 times more return on investment than Bluescope Steel. However, Actinogen Medical is 1.75 times more volatile than Bluescope Steel. It trades about 0.14 of its potential returns per unit of risk. Bluescope Steel is currently generating about 0.16 per unit of risk. If you would invest  2.40  in Actinogen Medical on September 1, 2024 and sell it today you would earn a total of  0.30  from holding Actinogen Medical or generate 12.5% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Actinogen Medical  vs.  Bluescope Steel

 Performance 
       Timeline  
Actinogen Medical 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Actinogen Medical has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in December 2024. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.
Bluescope Steel 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Bluescope Steel are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain essential indicators, Bluescope Steel may actually be approaching a critical reversion point that can send shares even higher in December 2024.

Actinogen Medical and Bluescope Steel Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Actinogen Medical and Bluescope Steel

The main advantage of trading using opposite Actinogen Medical and Bluescope Steel positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Actinogen Medical position performs unexpectedly, Bluescope Steel can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bluescope Steel will offset losses from the drop in Bluescope Steel's long position.
The idea behind Actinogen Medical and Bluescope Steel pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Other Complementary Tools

Fundamental Analysis
View fundamental data based on most recent published financial statements
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA